Abstract

Non-polyadenylated mRNAs of replication-dependent histones (RDHs) are synthesized by RNA polymerase II (Pol II) at histone locus bodies (HLBs). HLBs frequently associate with Cajal bodies (CBs), in which 3′-end processing factors for RDH genes are enriched; however, this association’s role in transcription termination of RDH genes remains unclear. Here, we show that Pol II pauses immediately upstream of transcript end sites of RDH genes and Mediator plays a role in this Pol II pausing through CBs’ association with HLBs. Disruption of the Mediator docking site for Little elongation complex (LEC)–Cap binding complex (CBC)–Negative elongation factor (NELF), components of CBs, interferes with CBs’ association with HLBs and 3′ Pol II pausing, resulting in increased aberrant unprocessed RDH gene transcripts. Our findings suggest Mediator’s involvement in CBs’ association with HLBs to facilitate 3′ Pol II pausing and subsequent 3′-end processing of RDH genes by supplying 3′-end processing factors.

Transcription termination is generally accompanied by the 3′-end processing of transcripts. Here the authors demonstrate a role for Mediator in transcript end site proximal pausing of replication-dependent histone genes.

Details

Title
The 3′ Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies’ association with histone locus bodies
Author
Suzuki, Hidefumi 1 ; Abe Ryota 1 ; Shimada Miho 1 ; Hirose Tomonori 1   VIAFID ORCID Logo  ; Hirose Hiroko 1 ; Noguchi Keisuke 1 ; Ike Yoko 1 ; Yasui Nanami 1 ; Furugori Kazuki 1 ; Yamaguchi Yuki 2   VIAFID ORCID Logo  ; Toyoda Atsushi 3   VIAFID ORCID Logo  ; Suzuki, Yutaka 4 ; Yamamoto Tatsuro 5 ; Saitoh Noriko 5 ; Sato Shigeo 6 ; Tomomori-Sato Chieri 6   VIAFID ORCID Logo  ; Conaway, Ronald C 7 ; Conaway, Joan W 7   VIAFID ORCID Logo  ; Takahashi Hidehisa 1 

 Yokohama City University Graduate School of Medical Science, Department of Molecular Biology, Yokohama, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139) 
 Tokyo Institute of Technology, School of Life Science and Technology, Yokohama, Japan (GRID:grid.32197.3e) (ISNI:0000 0001 2179 2105) 
 National Institute of Genetics, Comparative Genomics Laboratory, Shizuoka, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350) 
 The University of Tokyo, Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, Chiba, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X) 
 The Cancer Institute of JFCR, Division of Cancer Biology, Tokyo, Japan (GRID:grid.486756.e) (ISNI:0000 0004 0443 165X) 
 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591) 
 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591); University of Kansas Medical Center, Department of Biochemistry & Molecular Biology, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2669223353
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.